Veradermics MANE
NYSE MANE
$121.37 +3.56 (+3.02%)
At close: Sep 30, 2026 · 4:00 PM EDT

Veradermics (MANE) Free Cash Flow (2025 - 2026)

Updated

Veradermics (MANE) posted Free Cash Flow of -$14.52 million for Q2 2026, compared with -$15.68 million a year earlier.

Analysis

Veradermics (MANE) Free Cash Flow (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Free Cash Flow at Veradermics was -$64.74 million; for FY2025, it was -$71.63 million.

  • In prior years, Veradermics' Free Cash Flow was -$23.7 million in FY2024.
  • The Q2 2026 figure stands as the highest quarterly Free Cash Flow since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 Veradermics 5.07 Bn 5.07 Bn - -14.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.52 Mn
Mar 31, 2026 -21.20 Mn
Jun 30, 2025 -15.68 Mn
Mar 31, 2025 -13.34 Mn
API Access

Veradermics Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=MANE&period=max&api_key=YOUR_API_KEY